• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

International Alliance of ALS/MND Associations

  • Members' Login
  • Contact
  • Join the Alliance
  • Donate
  • Understanding ALS/MND
    • What is ALS/MND
    • Genetics
    • Diagnosis
    • Glossary
    • Navigating the Community
  • Find a Member Association
  • Support for PALS & CALS
    • Fundamental Rights for People with ALS/MND and Caregivers
    • Research
      • Clinical Trial Registry Accuracy and Maintenance in ALS/MND Research
      • Open Science
        • Open Label Extension
      • Expanded Access
      • Understanding ALS/MND Research
      • Improving Regulatory Pathways
      • Right to Try
      • US FDA Orphan Drug Designation
      • Unproven Treatments
    • Advocacy
      • Advocacy Toolkit
      • Emergency Preparedness Toolkit
      • Equitable Access to Therapies
      • Recommendations for Trial Sponsors
    • Clinical Care
      • Genetic Counselling & Testing
      • Mental Health Support
      • Nursing and Symptom Management
      • Nutrition, Swallowing and Saliva
      • Activities of Daily Living and Occupational Therapy
      • Muscles, Mobility and Exercise
      • Respiratory Care
      • Speech and Communication
      • Voice Preservation
      • Support for Family & Caregivers
      • Technology
      • Global Clinic Locator
    • Drugs in Development
      • Masitinib
      • NurOwn
      • CNM-Au8
      • ILB
      • AstroRx
      • Neuronata-R / Lenzumestrocel
      • PrimeC
      • NP001
      • Pridopidine
      • SOD1 Therapies and Trials
      • C9orf72 Therapies and Trials
      • SPG302
      • Regulatory T Cell Enhancing Therapies
      • Ulefnersen
    • Approved Drugs
      • Nuedexta
      • Radicava / Edaravone
      • Riluzole / Tiglutik
      • Rozebalamin / Methylcobalamin
      • Tofersen / Qalsody
    • Drugs No Longer in Development
      • AMX0035
      • Reldesemtiv
      • Arimoclomol
      • TUDCA
      • CuATSM
  • Support for Health Professionals
    • Breaking the News in ALS/MND
    • R.A.C.E. to Diagnose ALS/MND
  • Programs & Events
    • Calendar of Events
    • Global Day Calendar
    • Alliance Meeting
    • Allied Professionals Forum
    • “Day in the Life Of” Suite
    • Alliance Webinars
    • ALS/MND Connect
    • March of Faces
    • Patient Fellows Program
    • Alliance Fellows
    • SEED Grant Program
    • Awards
      • Forbes Norris Award
      • Humanitarian Award
      • Allied Health Professional Award
      • Student Innovation Award
  • About
    • Who We Are
    • ALS/MND Health Literacy Map
    • Board of Trustees
    • Councils, Forums & Committees
      • Scientific Advisory Council
      • PALS and CALS Advisory Council
      • Advocacy and Public Policy Forum
      • Research Directors Forum
      • Governance Committee
      • Finance Committee
    • Staff
    • History
    • Newsletter Archive
  • Members
    • Member Registration
    • Forgot Password

History

The International Alliance of ALS/MND Associations was founded in 1992 by a small group of national ALS/MND associations that shared a common goal: to strengthen support for people living with ALS/MND by working together across borders.

What began as a collaborative network has grown into a global community of more than 80 member associations in over 40 countries. Today, the Alliance connects organizations, healthcare professionals, researchers, people living with ALS/MND, caregivers, and advocates to improve care, advance research, and build a world free of ALS/MND.

How the Alliance Began

Based on recollections by Mavis Gallienne, Wendy Abrams, Rodney Harris, and Peter Cardy (December 2012).

The idea for an international ALS/MND network emerged in 1987–1988, shortly after Peter Cardy became Chief Executive Officer of the MND Association of England, Wales and Northern Ireland.

The Association launched an annual international research meeting — the event that would later become the International Symposium on ALS/MND. Originally titled Who Is Out There Researching Into MND?, the meeting brought together researchers and representatives from ALS/MND organizations around the world.

As these meetings grew, so did conversations about creating an international organization that could connect national associations, strengthen support for people living with ALS/MND, and encourage global research collaboration. Those discussions led to the founding of the International Alliance of ALS/MND Associations.

The Founding of the Alliance

The Alliance was formally established during a meeting held in Solihull, Birmingham, England, from November 4–6, 1992. Representatives from ALS/MND associations agreed to create an international organization dedicated to collaboration, shared learning, advocacy, and research.

Read the Official Notes from the Founding Meeting

Marking 30 Years

In 2022, the Alliance celebrated its 30th anniversary with a video reflecting on its history and the people who helped build the global ALS/MND community.

Growing a Global Community

Over the past three decades, the Alliance has evolved from a network centred on an annual meeting into a year-round global organization supporting collaboration, education, advocacy, and research.

Expanding our global reach

Membership has expanded to more than 80 organizations in over 40 countries, with increasing engagement in Latin America, Africa, South Asia, and other regions where ALS/MND services and research infrastructure continue to develop. Regional collaborations, including ALS Africa and ELATAM, have strengthened local leadership and knowledge sharing.

Creating new opportunities for collaboration

The Alliance has also launched initiatives that bring more voices into the global ALS/MND community. These include the Patient Fellows Program, which supports people living with ALS/MND and caregivers to participate in international research discussions; the Allied Professionals Forum, which connects healthcare professionals worldwide; and the SEED Grant Program, which provides early-stage funding to strengthen ALS/MND research capacity in low- and middle-income countries.

In 2025, the Alliance published the ALS/MND Health Literacy Map, a global framework that identifies the information and support people living with ALS/MND, caregivers, and families need throughout the disease journey. The framework now guides much of the Alliance’s education and communications work.

Guiding our work today

Today, the Alliance continues to unite organizations around a shared vision of a world free of ALS/MND. Its 2026–2028 Strategy focuses on improving quality of life, expanding inclusion, raising global awareness, strengthening research collaboration, building organizational capacity, and growing the international ALS/MND community.

Alliance Chairs

The following individuals have served as Chair of the International Alliance of ALS/MND Associations:

Eithne Frost
MND Association of Ireland
Mavis Gallienne
MND Australia, UK
Wendy Abrams
Les Turner ALS Foundation, USA
Diane Heron
MND Association of South Africa
Rod Harris
MND Victoria, Australia
Gudjon Sigurdsson
MND Iceland
Jeffrey Deitch
ALS Hope Foundation, USA
Carol Birks
MND Australia
Steve Bell
MND Association, UK
Calaneet Balas
The ALS Association, USA (2018–2025)
Tammy Moore
ALS Society of Canada (2025–present)

Primary Sidebar

About

  • Who We Are
  • Board of Trustees
  • Councils, Forums & Committees
    • PALS and CALS Advisory Council
    • Scientific Advisory Council
    • Advocacy and Public Policy Forum
    • Research Directors Forum
    • Governance Committee
    • Finance Committee
  • Staff
  • History
  • Newsletter Archive
    • Meetings
  • Awards

  • Malcolm Buck, Australia

    Malcolm Buck, Australia

  • Len Johnrose, England

    Len Johnrose, England

  • Zelina Brito, Brazil

    Zelina Brito, Brazil

  • Juvenal Bayona Romero, Colombia

    Juvenal Bayona Romero, Colombia

  • Antonio Ventriglia, Belgium

    Antonio Ventriglia, Belgium

  • Dorette Lüdi, Switzerland

    Dorette Lüdi, Switzerland

  • Steve

    Steve

  • Chun Ju Xiao, China

    Chun Ju Xiao, China

  • Monica Soriano, Argentina

    Monica Soriano, Argentina

  • Maria Lucia Wood Saldanha, Brazil

    Maria Lucia Wood Saldanha, Brazil

  • Cassio Fernando da Silva, Brazil

    Cassio Fernando da Silva, Brazil

  • Gudjon Sigurdsson, Iceland

    Gudjon Sigurdsson, Iceland

  • Seckin McGuirk, England

    Seckin McGuirk, England

  • Elisabeth Zahnd, Switzerland

    Elisabeth Zahnd, Switzerland

  • João Marcos Andrietta, Brazil

    João Marcos Andrietta, Brazil

  • Alejandro Aquino, Argentina

    Alejandro Aquino, Argentina

  • Lin Yong Yi, Taiwan

    Lin Yong Yi, Taiwan

  • Steve Gallagher, Canada

    Steve Gallagher, Canada
    Picture1

  • Danny Reviers, Belgium

    Danny Reviers, Belgium

  • Osiel Mendoza, USA

    Osiel Mendoza, USA

  • David Bishop, UK

    David Bishop, UK

  • PALS and CALS, Singapore

    PALS and CALS, Singapore

  • Marco Antonio Alvarez Mercado, Mexico

    Marco Antonio Alvarez Mercado, Mexico

  • Mike Cels, Canada

    Mike Cels, Canada

  • Verónica Isabel Castro Molina, Argentina

    Verónica Isabel Castro Molina, Argentina

  • Chris McCauley, Canada

    Chris McCauley, Canada

  • Jan Zuring, Netherlands

    Jan Zuring, Netherlands

  • Jorge Luis Fernández Romero, Mexico

    Jorge Luis Fernández Romero, Mexico

  • JP

    JP

  • Oliver Juenke, Germany

    Oliver Juenke, Germany

  • Carlos Gomez Matallanas, Spain

    Carlos Gomez Matallanas, Spain

  • Mauril Belanger, Canada

    Mauril Belanger, Canada

  • Irene McCaughey, Australia

    Irene McCaughey, Australia

  • Ian Gale, Australia

    Ian Gale, Australia

  • Frank Taylor, USA

    Frank Taylor, USA

  • Peng Yi-Wen, Taiwan

    Peng Yi-Wen, Taiwan

  • Eddy LeFrançois, Canada

    Eddy LeFrançois, Canada

  • Vincent Bourque, Canada

    Vincent Bourque, Canada
    vincent_bourque

  • Ali Var, Turkey

    Ali Var, Turkey

  • Daniel Hare, USA

    Daniel Hare, USA

  • Oliver Juenke, Germany

    Oliver Juenke, Germany

  • Yolanda Armendariz, Mexico

    Yolanda Armendariz, Mexico

  • Liam Dwyer, England

    Liam Dwyer, England

  • Lombana, Spain

    Lombana, Spain

  • Nicholas (Nic) Bowman, South Africa

    Nicholas (Nic) Bowman, South Africa

  • Dick Dayton, USA

    Dick Dayton, USA

  • Barry de Reuver, Netherlands

    Barry de Reuver, Netherlands

  • Timothy Holman, Switzerland

    Timothy Holman, Switzerland

  • Wilfried Leusing, Germany

    Wilfried Leusing, Germany

  • David Watson, Scotland

    David Watson, Scotland

Learn more about the March of Faces

Footer

Stay connected to the global ALS/MND community.

Subscribe to receive our newsletter and updates on how to get involved across the Alliance network.

 
This field is for validation purposes and should be left unchanged.
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube
Return to top of page

Contact | Disclaimer | Privacy Notice & Cookies | Sitemap

Copyright © 2026 The International Alliance of ALS/MND Associations. All rights reserved.


Registered in England: Charity Number 1079504 · Site built by graphics.coop · Powered by WordPress · Members' login